Published in J Neurol Sci on September 26, 2005
Neuropsychological assessment of dementia. Annu Rev Psychol (2009) 1.76
Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. Parkinsonism Relat Disord (2008) 1.16
Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord (2008) 1.16
Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease. J Neurol (2008) 1.15
Magnetic resonance imaging of Huntington's disease: preparing for clinical trials. Neuroscience (2009) 1.14
Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure. Neuroimage (2007) 1.12
Early atrophy of pallidum and accumbens nucleus in Huntington's disease. J Neurol (2010) 1.04
Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front Neurosci (2013) 0.99
The caudate: a key node in the neuronal network imbalance of insomnia? Brain (2013) 0.98
Huntington's disease: changes in saccades and hand-tapping over 3 years. J Neurol (2010) 0.94
Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats. Exp Neurol (2010) 0.93
Callosal Compromise Differentially Affects Conflict Processing and Attentional Allocation in Alcoholism, HIV, and Their Comorbidity. Brain Imaging Behav (2008) 0.91
Complexity and heterogeneity: what drives the ever-changing brain in Huntington's disease? Ann N Y Acad Sci (2008) 0.91
Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J Neural Transm (Vienna) (2006) 0.91
Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease. Arch Clin Neuropsychol (2012) 0.90
Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease. J Neurol (2009) 0.89
Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis. Neurodegener Dis (2012) 0.89
Ecological validity and neuroanatomical correlates of the NIH EXAMINER executive composite score. J Int Neuropsychol Soc (2013) 0.88
The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury. Exp Neurol (2011) 0.86
Psychogenic or neurogenic origin of agrammatism and foreign accent syndrome in a bipolar patient: a case report. Ann Gen Psychiatry (2007) 0.86
Huntington's Disease and Striatal Signaling. Front Neuroanat (2011) 0.86
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci (2014) 0.86
Depression in patients with Huntington disease correlates with alterations of the brain stem raphe depicted by transcranial sonography. J Psychiatry Neurosci (2011) 0.85
Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec (Hoboken) (2011) 0.84
Executive functions in premanifest Huntington's disease. Mov Disord (2013) 0.84
Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study. Neurobiol Aging (2010) 0.83
Quantitative and qualitative assessment of structural magnetic resonance imaging data in a two-center study. BMC Med Imaging (2012) 0.83
The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study. Brain Behav (2015) 0.80
Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report. Rev Colomb Psiquiatr (2008) 0.79
Clinical severity of Huntington's disease does not always correlate with neuropathologic stage. Mov Disord (2012) 0.79
Motor network structure and function are associated with motor performance in Huntington's disease. J Neurol (2016) 0.78
Linking white matter and deep gray matter alterations in premanifest Huntington disease. Neuroimage Clin (2016) 0.77
Early grey matter changes in structural covariance networks in Huntington's disease. Neuroimage Clin (2016) 0.76
Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature. PLoS One (2017) 0.75
Pre- and post- GPi DBS neuropsychological profiles in a case of X-linked dystonia-Parkinsonism. Clin Neuropsychol (2011) 0.75
Monitoring Huntington's disease progression through preclinical and early stages. Neurodegener Dis Manag (2012) 0.75
The BACHD Rat Model of Huntington Disease Shows Signs of Fronto-Striatal Dysfunction in Two Operant Conditioning Tests of Short-Term Memory. PLoS One (2017) 0.75
The application of rules in morphology, syntax and number processing: a case of selective deficit of procedural or executive mechanisms? Neurocase (2010) 0.75
Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord (2010) 2.34
Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity? Dev Med Child Neurol (2008) 2.11
Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol (2006) 1.86
REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain (2008) 1.77
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol (2011) 1.40
The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One (2010) 1.32
Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging. Hum Brain Mapp (2010) 1.23
A new missense mutation in the leptin gene causes mild obesity and hypogonadism without affecting T cell responsiveness. J Clin Endocrinol Metab (2010) 1.19
The cerebral control of speech tempo: opposite relationship between speaking rate and BOLD signal changes at striatal and cerebellar structures. Neuroimage (2005) 1.17
Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Paediatr Neurol (2007) 1.15
Enhanced visualization of blurred gray-white matter junctions in focal cortical dysplasia by voxel-based 3D MRI analysis. Epilepsy Res (2005) 1.13
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One (2012) 1.09
GABAergic dysfunction in essential tremor: an 11C-flumazenil PET study. J Nucl Med (2010) 1.09
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum Mol Genet (2010) 1.09
Transdermal rotigotine for the perioperative management of Parkinson's disease. J Neural Transm (Vienna) (2010) 1.08
Histopathological analysis of skeletal muscle in patients with Parkinson's disease and 'dropped head'/'bent spine' syndrome. Parkinsonism Relat Disord (2009) 1.08
Spatial imagery in deductive reasoning: a functional MRI study. Brain Res Cogn Brain Res (2002) 1.07
Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway. J Biol Chem (2002) 1.04
Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry. Br J Psychiatry (2006) 1.04
Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures. Neuroimage (2009) 1.04
Laryngospasm: an underdiagnosed symptom of X-linked spinobulbar muscular atrophy. Neurology (2005) 1.01
Inflammatory dysregulation of blood monocytes in Parkinson's disease patients. Acta Neuropathol (2014) 1.00
MRI-based functional neuroimaging in ALS: an update. Amyotroph Lateral Scler (2009) 0.99
Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice. Mol Ther (2007) 0.99
The role of the unaffected hemisphere in motor recovery after stroke. Hum Brain Mapp (2010) 0.98
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI study. Neuroreport (2004) 0.96
Neuroanatomical patterns of cerebral white matter involvement in different motor neuron diseases as studied by diffusion tensor imaging analysis. Amyotroph Lateral Scler (2012) 0.96
Grasping premanifest Huntington's disease - shaping new endpoints for new trials. Mov Disord (2010) 0.95
Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol (2007) 0.95
Diffusion tensor magnetic resonance imaging in the analysis of neurodegenerative diseases. J Vis Exp (2013) 0.95
Body fat distribution as a risk factor for cerebrovascular disease: an MRI-based body fat quantification study. Cerebrovasc Dis (2013) 0.94
Emotional responding in amyotrophic lateral sclerosis. J Neurol (2005) 0.92
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease. PLoS Curr (2011) 0.92
MRI brain lesion patterns in patients in anoxia-induced vegetative state. J Neurol Sci (2007) 0.92
Diffusion tensor imaging and tractwise fractional anisotropy statistics: quantitative analysis in white matter pathology. Biomed Eng Online (2007) 0.92
Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna) (2013) 0.91
Intersubject variability in the analysis of diffusion tensor images at the group level: fractional anisotropy mapping and fiber tracking techniques. Magn Reson Imaging (2008) 0.91
Striatal gray matter loss in Huntington's disease is leftward biased. Mov Disord (2007) 0.91
Quantification of human body fat tissue percentage by MRI. NMR Biomed (2011) 0.91
Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders. Amyotroph Lateral Scler (2008) 0.91
Quetiapine in primary insomnia: a pilot study. Psychopharmacology (Berl) (2007) 0.90
At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists. Brain (2009) 0.90
Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis (2005) 0.90
Laryngospasm in neurological diseases. Neurocrit Care (2006) 0.89
Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.89
Parkinsonism in a population of northern Tanzania: a community-based door-to-door study in combination with a prospective hospital-based evaluation. J Neurol (2009) 0.89
Stability of white matter changes related to Huntington's disease in the presence of imaging noise: a DTI study. PLoS Curr (2011) 0.89
Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology (2004) 0.89
Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord (2010) 0.89
Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. BMC Neurol (2009) 0.88
Head of the caudate nucleus is most vulnerable in chorea-acanthocytosis: a voxel-based morphometry study. Mov Disord (2006) 0.88
Voxel-based 3D MRI analysis for the detection of epileptogenic lesions at single subject level. Epilepsia (2009) 0.87
The combination of dopa-responsive parkinsonian syndrome and motor neuron disease. Neurodegener Dis (2009) 0.87
Parkinson's disease risk score: moving to a premotor diagnosis. J Neurol (2011) 0.87
Novel mutation in the ALS2 gene in juvenile amyotrophic lateral sclerosis. Ann Neurol (2005) 0.86
Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease. J Neurol (2009) 0.86
Eye movement impairments in Parkinson's disease: possible role of extradopaminergic mechanisms. BMC Neurol (2012) 0.86
Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul Disord (2007) 0.86
Brain responses to emotional stimuli in patients with amyotrophic lateral sclerosis (ALS). J Neurol (2007) 0.86
Creatine supplementation lowers brain glutamate levels in Huntington's disease. J Neurol (2005) 0.86
Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease. J Neurol (2009) 0.84
Cortical grey matter alterations in idiopathic restless legs syndrome: An optimized voxel-based morphometry study. Mov Disord (2007) 0.84
Can lesions to the motor cortex induce amyotrophic lateral sclerosis? J Neurol (2013) 0.84
Cortical plasticity in amyotrophic lateral sclerosis: motor imagery and function. Neurorehabil Neural Repair (2007) 0.84
Wiskott-Aldrich syndrome protein is an effector of Kit signaling. Blood (2009) 0.84
Functional connectivity within the default mode network is associated with saccadic accuracy in Parkinson's disease: a resting-state FMRI and videooculographic study. Brain Connect (2013) 0.84
Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov Disord (2006) 0.84
Unusually quick resorption of an intracerebral hemorrhage in congenital afibrinogenemia. Neuroradiology (2002) 0.84
Further evidence for aberrant prefrontal salience coding in schizophrenia. Front Behav Neurosci (2010) 0.83
Deep brain stimulation and behavioural changes: is comedication the most important factor? Neurodegener Dis (2011) 0.83
Dysphagia due to unilateral infarction in the vascular territory of the anterior insula. Dysphagia (2008) 0.83
On the role of quantitative brain imaging in the differential diagnosis of speech disorders. Psychiatry Clin Neurosci (2002) 0.83
Empathic competencies in violent offenders. Psychiatry Res (2013) 0.83
Automatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level. J Neural Transm (Vienna) (2008) 0.82
Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Mov Disord (2010) 0.82
Restless legs syndrome in a population of northern Tanzania: a community-based study. Mov Disord (2010) 0.82
Do eye movement impairments in patients with small vessel cerebrovascular disease depend on lesion load or on cognitive deficits? A video-oculographic and MRI study. J Neurol (2014) 0.82
Primary progressive aphasia accompanied by environmental sound agnosia: a neuropsychological, MRI and PET study. Psychiatry Res (2006) 0.81
Intracerebral hemorrhage in a patient with glycogenosis type II (Pompe disease): is there a pathophysiological relationship? Muscle Nerve (2008) 0.81
Magnetic resonance investigation of the upper spinal cord in pure and complicated hereditary spastic paraparesis. Eur Neurol (2005) 0.81
Parkinson's disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis. J Neurol (2012) 0.81
Cerebral white matter alterations in idiopathic restless legs syndrome, as measured by diffusion tensor imaging. Mov Disord (2008) 0.81
Complementary image analysis of diffusion tensor imaging and 3-dimensional t1-weighted imaging: white matter analysis in amyotrophic lateral sclerosis. J Neuroimaging (2011) 0.81
Separating functional and structural damage in persistent vegetative state using combined voxel-based analysis of 3-D MRI and FDG-PET. J Neurol Sci (2005) 0.81
MR-pathologic comparison of the upper spinal cord in different motor neuron diseases. Eur Neurol (2005) 0.81
Standardized calculation of brain parenchymal fraction: an approach to objective assessment of cerebral atrophy. AJNR Am J Neuroradiol (2003) 0.81
Wilson's disease in psychiatric patients. Psychiatry Clin Neurosci (2002) 0.81
Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach. Neuroimage Clin (2013) 0.81
The bootstrap and cross-validation in neuroimaging applications: estimation of the distribution of extrema of random fields for single volume tests, with an application to ADC maps. Hum Brain Mapp (2007) 0.81
Directional colour encoding of the human thalamus by diffusion tensor imaging. Neurosci Lett (2008) 0.80
Complex chemoattractive and chemorepellent Kit signals revealed by direct imaging of murine mast cells in microfluidic gradient chambers. Integr Biol (Camb) (2013) 0.80
Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetate. Eur Neurol (2011) 0.80
Cognitive decline in the behavioral variant of frontotemporal dementia. Int Psychogeriatr (2010) 0.80
Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS One (2013) 0.80
The role of encoding strategies in the verbal memory performance in patients with schizophrenia. J Neuropsychol (2011) 0.80
Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study. J Neurol (2015) 0.80
18FDG-PET in epilepsies of infantile onset with pharmacoresistant generalised tonic-clonic seizures. Epilepsy Res (2004) 0.80